Australia

5 Vaccines Approved for Use in Australia

Protein Subunit

Novavax

Nuvaxovid

Approved in 37 countries
16 trials in 12 countries
Approval Source: health.gov.au
RNA

Moderna

Spikevax

Approved in 86 countries
63 trials in 22 countries
Approval Source: pm.gov.au
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: abc.net.au
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: tga.gov.au
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Approval Source: theguardian.com

19 in Clinical Trials in Australia

Protein Subunit

Clover

SCB-2019

12 trials in 11 countries
Protein Subunit

Novavax

Nuvaxovid

Approved in 37 countries
16 trials in 12 countries
Protein Subunit

Sanofi/GSK

Recombinant Protein

6 trials in 7 countries
Protein Subunit

Vaxine/CinnaGen Co.

SpikoGen

Approved in 1 country
7 trials in 2 countries
RNA

Moderna

Spikevax

Approved in 86 countries
63 trials in 22 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Protein Subunit

Icosavax

IVX-411

2 trials in 1 country
Protein Subunit

Novavax

ICC Vaccine

2 trials in 1 country
Protein Subunit

Novavax

SII B.1.351

2 trials in 1 country
Protein Subunit

Novavax

SII B.1.617.2

2 trials in 1 country
Protein Subunit

Novavax

SII Bivalent

2 trials in 1 country
VLP

SpyBiotech

RBD SARS-CoV-2 HBsAg VLP

2 trials in 1 country
Protein Subunit

University of Melbourne

DoCo-Pro-RBD-1

DNA

Symvivo

bacTRL-Spike

DNA

University of Sydney

COVIGEN

RNA

University of Melbourne

MIPSCo-mRNA-RBD-1

Non Replicating Viral Vector

EnGeneIC

COVID-19-EDV

Non Replicating Viral Vector

Tetherex Pharmaceuticals Corporation

SC-Ad6-1

RNA

EyeGene Inc

EG-COVID-003

2 trials in 1 country

1 Vaccines with Trials in Australia are No Longer Progressing

Protein Subunit

Queensland

Sclamp